Cardiology Flashcards
(223 cards)
CVD risk factors (modifiable) (9)
Obesity
Hypertension
Smoking
Sedentary lifestyle
High LDL cholesterol
Poor diet
Alcohol drinking
Cocaine use
Uncontrolled DM
CVD risk factors (non-modifiable) (7)
Age
Male gender
Ethnicity (South Asian, African, Caribbean)
Family history
Menopause
Genetic predisposition (hyperlipidaemia)
Socioeconomic status
Normal blood pressure ranges and hypertension staging
90/60 - 120-80
Prehypertension - 120/80 +
Stage 1: 140/90 +
Stage 2: 160/100 +
Stage 3 >180/120
Describe the 3 characteristic features of typical stable angina
Central crushing chest pain that can radiate to jaw, shoulders or left arm
- Caused by exertion
- Is relieved by GTN spray or rest
can also be Caused by heavy meals, cold weather, strong emotion.
Other causes of an angina exacerbation
heavy meals, cold weather, strong emotion.
Give some primary preventions of cardiovascular disease
QRISK3 score (10 year risk calculator of MI or stroke)
Patients with CKD or T1DM taking statins
Checking lipids, LFTs, BP regularly
Pathophysiology of stable angina
Usually caused by atherosclerosis, narrowing of coronary arteries (>70% stenosis) causes reduced blood flow to heart, which is unable to meet the metabolic demands of the muscle on exertion (myocardial ischaemia). This usually subsides with rest.
Pathogenesis of atherosclerotic plaque formation
- High LDL causes them to deposit and oxidise in tunica intima, activating endothelial cells which present leukocyte adhesion molecules.
- Leukocytes move into intima and attract monocytes (macrophages/T helper cells)
- Macrophages take up oxidised LDL and form foam cells, which release IGF-1 causing smooth muscle to migrate to intima from media.
- Smooth muscle proliferation forms fibrous cap.
- As foam cells die they release lipid content, growth factors and cytokines, growing plaque.
- Plaque either occludes vessel or ruptures, triggering platelet aggregation and clotting.
Signs/symptoms of stable angina
- Central crushing chest pain which may or may not radiate to left arm, neck and jaw. (<5 mins long)
- Pain is provoked by exertion or stress
- Pain is relieved by rest/nitrates
May cause sweating, dyspnoea, fatigue, palpitations and syncope
Investigations for stable angina
- 12 lead ECG: Normal (may show ST depression, ruling out NSTEMI/STEMI)
- CT coronary angiography (GOLD) to highlight stenosis
- FBC, TFT, LFT, HbA1C to rule out causative pathologies
Management of stable angina
- Acute relief of symptoms: sublingual GTN spray
- Lifestyle changes (lose weight, exercise, lipid/diabetes/HTN management)
- Long term treatment: Beta blocker e.g. propanolol (CI: Asthma) or CCB e.g. amlodipine (CI: Heart failure) (must be non rate limiting so doesnt cause bradycardia)
Then dual therapy if needed - Long term prevention may be added: 3As (Aspirin, atorvastatin, ACEi (Ramipril))
If pharmacologically unsuccessful, what surgical options are available to treat angina? With pros and cons
- Percutaneous coronary intervention (PCI) - Balloon stent opens vessel. (less invasive, but higher risk of stenosis)
- Coronary artery bypass graft (CABG) - chest opened along sternum, taking graft vein from patient’s leg and sewing onto artery to bypass stenosis. (better outcomes, more invasive/greater risks. Leaves midline sternotomy scar)
What 3 conditions make up Acute Coronary Syndrome
Unstable angina
- NSTEMI
- STEMI
Occlusion, infarction, ECG, troponin features in ACS conditions
- Unstable Angina: Partial occlusion, no infarction (just ischaemia), ECG usually normal (can show ST depression/T wave inversion), troponin normal
- NSTEMI: Major occlusion, subendothelial infarction, ST depression/T wave inversion/Pathological Q waves, troponin elevated
- STEMI: Total occlusion, transmural infarction, ST elevation/T wave inversion/New LBBB, troponin elevated
ACS signs/symptoms
Central crushing chest pain that may or may not radiate to left arm and neck. Symptoms continue at rest and last >~20 mins
- Dyspnoea, sweating, nausea, palpitations, anxiety (impending sense of doom in MI)
Investigations in ACS
- ECG - see ECG changes cards (if ST elevation or new bundle branch block, STEMI)
- CT coronary angiography - assess occlusion/stenosis
- Troponin T - raised in STEMI, NSTEMI (no ST elevation but troponin = NSTEMI)
What are troponins, give alternative causes of raised troponin
Cardiac muscle proteins. Released from cardiac muscle in severe ischaemia/infarction.
Alternative causes of raised troponin:
- Chronic renal failure
- Sepsis
- Myocarditis
- Aortic dissection
- Pulmonary embolism
Other imaging warranted in cases of MI
Chest X ray - check for pulmonary oedema
Echocardiogram - assess heart damage
Treatment of NSTEMI or unstable angina
1 - Acute management: MONAC (AB)
M - Morphine
O - Oxygen (if saturation falls below 94%)
N - Nitrates (GTN spray)
A - Aspirin (dual antiplatelet with C)
C - Clopidogrel (P2Y12 inhibitor) or ticagrelor
(A)- anticoagulant (LMWH) may be needed
(B) - Beta blocker may be needed
2 - Risk stratification:
GRACE Score conducted to calculate 6 month risk of repeat MI or mortality.
If risk is medium or high (>3%), or patient unstable, conduct PCI (percutaneous coronary intervention)
STEMI treatment
1 - Acute management: MONAC (AB)
2 - Surgical intervention needed!
- <12 hours since symptom onset and PCI available within 2 hours: PCI. If not, thrombolysis with alteplase, with anticoagulant such as unfractioned heparin. Aspirin/ticagrelor may also be given
Coronary angiography and ECG to assess success of treatment
Complications of MI
DREAD
D - Dressler’s syndrome
R - Rupture of heart septum or papillary muscles
E(fgh) - Heart Failure
A - Arrhythmia/Aneurysm
D - Death
Mitral regurgitation
Cardiac arrest
Secondary prevention of CVD
Pharmacological: 4A
- Aspirin (+- clopidogrel)
- Atenolol (Beta blocker)
- Atorvastatin
- ACEi (Ramipril)
Lifestyle:
- Exercise
- Diet change (Mediterranean best)
- Smoking cessation
- reduced alcohol intake
- Diabetes/HTN control
- Cardiac rehabilitation
Side effects of statins
- Myopathy (creatine kinase must be checked if any muscle pain/weakness)
- Type 2 diabetes
- Haemorrhagic stroke
Aspirin MoA
Antiplatelet: COX-1 inhibition - preventing synthesis of thromboxane A2